Exploratory Phase II Multicenter, Open-Label, Clinical Trial of ST266, a Novel Secretome for Treatment of Persistent Corneal Epithelial Defects.
- DOI
- 10.1167/tvst.11.1.8
- Published
- 2022 Jan 3
- Container
- Translational vision science & technology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1167/tvst.11.1.8,
title = {Exploratory Phase II Multicenter, Open-Label, Clinical Trial of ST266, a Novel Secretome for Treatment of Persistent Corneal Epithelial Defects.},
author = {Jeng BH and Hamrah P and Kirshner ZZ and Mendez BC and Wessel HC and Brown LR and Steed DL},
year = {2022},
journal = {Translational vision science \& technology},
doi = {10.1167/tvst.11.1.8},
url = {https://doi.org/10.1167/tvst.11.1.8}
}RIS
TY - JOUR TI - Exploratory Phase II Multicenter, Open-Label, Clinical Trial of ST266, a Novel Secretome for Treatment of Persistent Corneal Epithelial Defects. AU - Jeng BH AU - Hamrah P AU - Kirshner ZZ AU - Mendez BC AU - Wessel HC AU - Brown LR AU - Steed DL PY - 2022 JO - Translational vision science & technology DO - 10.1167/tvst.11.1.8 UR - https://doi.org/10.1167/tvst.11.1.8 ER -
APA
BH, J., P, H., ZZ, K., BC, M., HC, W., LR, B., & DL, S. (2022). Exploratory Phase II Multicenter, Open-Label, Clinical Trial of ST266, a Novel Secretome for Treatment of Persistent Corneal Epithelial Defects.. Translational vision science & technology. https://doi.org/10.1167/tvst.11.1.8
Source records
- pubmed · retrieved 2026-09-26T18:18:10.653Z